As of 2024-09-13, the Relative Valuation of Intra-Cellular Therapies Inc (ITCI) is (9.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 75.22 USD, the upside of Intra-Cellular Therapies Inc based on Relative Valuation is -113.3%.
The range of the Relative Valuation is (7.06) - (12.77) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.3x - 16.0x | 10.4x |
| Forward P/E multiples | 8.8x - 19.5x | 14.6x |
| Fair Price | (7.06) - (12.77) | (9.98) |
| Upside | -109.4% - -117.0% | -113.3% |
| Date | P/E |
| 2024-09-13 | -95.11 |
| 2024-09-12 | -94.24 |
| 2024-09-11 | -93.61 |
| 2024-09-10 | -92.16 |
| 2024-09-09 | -93.22 |
| 2024-09-06 | -92.13 |
| 2024-09-05 | -90.73 |
| 2024-09-04 | -91.03 |
| 2024-09-03 | -91.46 |
| 2024-08-30 | -91.81 |
| 2024-08-29 | -90.53 |
| 2024-08-28 | -91.17 |
| 2024-08-27 | -92.56 |
| 2024-08-26 | -93.32 |
| 2024-08-23 | -93.31 |
| 2024-08-22 | -93.16 |
| 2024-08-21 | -94.83 |
| 2024-08-20 | -96.45 |
| 2024-08-19 | -94.88 |
| 2024-08-16 | -93.75 |
| 2024-08-15 | -94.30 |
| 2024-08-14 | -94.74 |
| 2024-08-13 | -94.37 |
| 2024-08-12 | -93.84 |
| 2024-08-09 | -92.22 |
| 2024-08-08 | -93.23 |
| 2024-08-07 | -92.24 |
| 2024-08-06 | -97.93 |
| 2024-08-05 | -97.47 |
| 2024-08-02 | -96.84 |
| 2024-08-01 | -98.97 |
| 2024-07-31 | -98.62 |
| 2024-07-30 | -97.84 |
| 2024-07-29 | -97.96 |
| 2024-07-26 | -100.71 |
| 2024-07-25 | -101.28 |
| 2024-07-24 | -96.81 |
| 2024-07-23 | -97.97 |
| 2024-07-22 | -95.82 |
| 2024-07-19 | -93.79 |
| 2024-07-18 | -93.89 |
| 2024-07-17 | -95.85 |
| 2024-07-16 | -98.43 |
| 2024-07-15 | -98.58 |
| 2024-07-12 | -97.88 |
| 2024-07-11 | -98.12 |
| 2024-07-10 | -96.83 |
| 2024-07-09 | -92.80 |
| 2024-07-08 | -89.65 |
| 2024-07-05 | -87.15 |